These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9704451)

  • 21. [Problem of creating "artificial blood" based on organofluorine compounds].
    Iarochkin VS; Koziner VB
    Patol Fiziol Eksp Ter; 1981; (3):78-87. PubMed ID: 6456440
    [No Abstract]   [Full Text] [Related]  

  • 22. [Characteristics of the body oxygen supply when replacing blood loss of moderate severity with an emulsion of perfluoroorganic compounds and with polyglucin].
    Iarochkin VS; Volos OP; Koziner VB
    Gematol Transfuziol; 1986 Jun; 31(6):43-7. PubMed ID: 2426156
    [No Abstract]   [Full Text] [Related]  

  • 23. Supporting tissue oxygenation during acute surgical bleeding using a perfluorochemical-based oxygen carrier.
    Keipert PE; Faithfull NS; Roth DJ; Bradley JD; Batra S; Jochelson P; Flaim KE
    Adv Exp Med Biol; 1996; 388():603-9. PubMed ID: 8798865
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of the influence of the aqueous phase bioconstituent environment on the F-19 T1 of perfluorocarbon blood substitute emulsions.
    Thomas SR; Pratt RG; Millard RW; Samaratunga RC; Shiferaw Y; Clark LC; Hoffmann RE
    J Magn Reson Imaging; 1994; 4(4):631-5. PubMed ID: 7949694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood substitutes in surgery.
    Burris D
    Ann Chir Gynaecol; 2001; 90(2):76-80. PubMed ID: 11459262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Blood coagulation in dogs following the compensation of acute blood loss with polyglucin and an emulsion of perfluoro compounds].
    Panchenko SM; Afonin NI
    Gematol Transfuziol; 1988 May; 33(5):29-31. PubMed ID: 2457535
    [No Abstract]   [Full Text] [Related]  

  • 27. Oxidative assessment of phospholipid-stabilized perfluorocarbon-based blood substitutes.
    Tarara TE; Malinoff SH; Pelura TJ
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1287-93. PubMed ID: 7849935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial blood substitutes.
    Schneider P
    Transfus Sci; 1992 Jul; 13(3):357-70. PubMed ID: 10148132
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro model to compare the oxygen offloading behaviour of dodecafluoropentane emulsion (DDFPe).
    Jayaraman MS; Graham K; Unger EC
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):783-789. PubMed ID: 30873883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood substitutes. What they are and how they might be used.
    Dong Q; Stowell CP
    Am J Clin Pathol; 2002 Dec; 118 Suppl():S71-80. PubMed ID: 14569814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Present trends in fluorocarbon-based blood substitutes.
    Riess JG
    Life Support Syst; 1984; 2(4):273-6. PubMed ID: 6527557
    [No Abstract]   [Full Text] [Related]  

  • 32. Fluorocarbon blood substitutes in Russia.
    Obraztsov VV
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1019-27. PubMed ID: 7849906
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies of blood substitutes].
    Ohyanagi H; Saitoh Y; Mitsuno T
    Nihon Rinsho; 1980; 38(4):1966-79. PubMed ID: 6447815
    [No Abstract]   [Full Text] [Related]  

  • 34. Emulsions of perfluorochemicals as blood substitutes.
    Sloviter HA; Mukherji B
    Acta Anaesthesiol Belg; 1984; 35 Suppl():61-8. PubMed ID: 6516760
    [No Abstract]   [Full Text] [Related]  

  • 35. An Overview of Two Human Trials of Perfluorocarbon Emulsions in Noncardiac Surgery.
    Spahn DR; Keipert PE
    Shock; 2019 Oct; 52(1S Suppl 1):116-118. PubMed ID: 28930917
    [No Abstract]   [Full Text] [Related]  

  • 36. New transfusion strategies: red cell substitutes.
    Winslow RM
    Annu Rev Med; 1999; 50():337-53. PubMed ID: 10073282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood substitutes in surgery.
    Cohn SM
    Surgery; 2000 Jun; 127(6):599-602. PubMed ID: 10840352
    [No Abstract]   [Full Text] [Related]  

  • 38. The initial response of blood leukocytes to incubation with perfluorocarbon blood substitute emulsions.
    McDonagh PF; Wilson DS
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):439-47. PubMed ID: 7493065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A second-generation blood substitute (perflubron emulsion) increases the blood solubility of modern volatile anesthetics in vitro.
    Cuignet OY; Baele PM; Van Obbergh LJ
    Anesth Analg; 2002 Aug; 95(2):368-72, table of contents. PubMed ID: 12145053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hematopoiesis in the dog in experiments with acute blood loss replaced by a PFC emulsion combined with polyglucin].
    Fedorov NA; Gusenova FM; Afonin NI; Akhsianov UU; Kontuganov NN
    Patol Fiziol Eksp Ter; 1984; (5):3-7. PubMed ID: 6083530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.